ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
imperatore
|
168 |
65K |
8 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
168
|
65K
|
8
|
|
Charts
|
PER |
Re:
Chart
|
|
imperatore
|
5.9K |
2.3M |
3 |
09/08/22 |
09/08/22 |
Charts
|
5.9K
|
2.3M
|
3
|
|
Charts
|
PER |
Re:
Chart
|
|
imperatore
|
5.9K |
2.3M |
3 |
09/08/22 |
09/08/22 |
Charts
|
5.9K
|
2.3M
|
3
|
|
Charts
|
PER |
Re:
Chart
|
|
imperatore
|
5.9K |
2.3M |
4 |
09/08/22 |
09/08/22 |
Charts
|
5.9K
|
2.3M
|
4
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
imperatore
|
3.5K |
1.0M |
4 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
imperatore
|
3.5K |
1.0M |
2 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
imperatore
|
3.5K |
1.0M |
1 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
ZEO |
Re:
large seller clearing out
|
|
imperatore
|
16 |
7.2K |
1 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
16
|
7.2K
|
1
|
|
Charts
|
PER |
Re:
Chart
|
|
imperatore
|
5.9K |
2.3M |
3 |
01/08/22 |
01/08/22 |
Charts
|
5.9K
|
2.3M
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
imperatore
|
31 |
7.9K |
2 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
31
|
7.9K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
imperatore
|
31 |
7.9K |
2 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
31
|
7.9K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
imperatore
|
31 |
7.9K |
3 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
31
|
7.9K
|
3
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
imperatore
|
3.5K |
1.0M |
3 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
3
|
|
Charts
|
PER |
Re:
Chart
|
|
imperatore
|
5.9K |
2.3M |
5 |
21/07/22 |
21/07/22 |
Charts
|
5.9K
|
2.3M
|
5
|
|
Charts
|
PER |
Re:
Chart
|
|
imperatore
|
5.9K |
2.3M |
1 |
19/07/22 |
19/07/22 |
Charts
|
5.9K
|
2.3M
|
1
|
|
Charts
|
PER |
Re:
Chart
|
|
imperatore
|
5.9K |
2.3M |
5 |
18/07/22 |
18/07/22 |
Charts
|
5.9K
|
2.3M
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe
|
|
imperatore
|
93 |
24K |
5 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
93
|
24K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe
|
|
imperatore
|
93 |
24K |
10 |
17/07/22 |
17/07/22 |
ASX - By Stock
|
93
|
24K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe
|
|
imperatore
|
93 |
24K |
4 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
93
|
24K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe
|
|
imperatore
|
93 |
24K |
4 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
93
|
24K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe
|
|
imperatore
|
93 |
24K |
11 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
93
|
24K
|
11
|
|
Charts
|
PER |
Re:
Chart
|
|
imperatore
|
5.9K |
2.3M |
6 |
12/07/22 |
12/07/22 |
Charts
|
5.9K
|
2.3M
|
6
|
|
Charts
|
PER |
Re:
Chart
|
|
imperatore
|
5.9K |
2.3M |
4 |
12/07/22 |
12/07/22 |
Charts
|
5.9K
|
2.3M
|
4
|
|
Charts
|
PER |
Re:
Chart
|
|
imperatore
|
5.9K |
2.3M |
13 |
11/07/22 |
11/07/22 |
Charts
|
5.9K
|
2.3M
|
13
|
|
Charts
|
PER |
Re:
Chart
|
|
imperatore
|
5.9K |
2.3M |
7 |
11/07/22 |
11/07/22 |
Charts
|
5.9K
|
2.3M
|
7
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
imperatore
|
3.5K |
1.0M |
1 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
Charts
|
PER |
Re:
Chart
|
|
imperatore
|
5.9K |
2.3M |
11 |
06/07/22 |
06/07/22 |
Charts
|
5.9K
|
2.3M
|
11
|
|
Charts
|
PER |
Re:
Chart
|
|
imperatore
|
5.9K |
2.3M |
3 |
01/07/22 |
01/07/22 |
Charts
|
5.9K
|
2.3M
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Proteomics and disease marker identification in DMD Webinar
|
|
imperatore
|
25 |
8.3K |
3 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
25
|
8.3K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
imperatore
|
88 |
22K |
5 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
88
|
22K
|
5
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
imperatore
|
3.5K |
1.0M |
7 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
imperatore
|
88 |
22K |
1 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
88
|
22K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
imperatore
|
88 |
22K |
1 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
88
|
22K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
imperatore
|
88 |
22K |
14 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
88
|
22K
|
14
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
imperatore
|
88 |
22K |
4 |
26/06/22 |
26/06/22 |
ASX - By Stock
|
88
|
22K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
imperatore
|
88 |
22K |
3 |
26/06/22 |
26/06/22 |
ASX - By Stock
|
88
|
22K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
imperatore
|
88 |
22K |
3 |
26/06/22 |
26/06/22 |
ASX - By Stock
|
88
|
22K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
imperatore
|
88 |
22K |
4 |
26/06/22 |
26/06/22 |
ASX - By Stock
|
88
|
22K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
imperatore
|
88 |
22K |
2 |
26/06/22 |
26/06/22 |
ASX - By Stock
|
88
|
22K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
imperatore
|
88 |
22K |
4 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
88
|
22K
|
4
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
imperatore
|
3.5K |
1.0M |
6 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2
|
|
imperatore
|
86 |
23K |
2 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
86
|
23K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2
|
|
imperatore
|
86 |
23K |
2 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
86
|
23K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2
|
|
imperatore
|
86 |
23K |
7 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
86
|
23K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2
|
|
imperatore
|
86 |
23K |
6 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
86
|
23K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2
|
|
imperatore
|
86 |
23K |
6 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
86
|
23K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2
|
|
imperatore
|
86 |
23K |
4 |
20/06/22 |
20/06/22 |
ASX - By Stock
|
86
|
23K
|
4
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
imperatore
|
3.5K |
1.0M |
5 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
imperatore
|
3.5K |
1.0M |
2 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Long COVID-19 strategic collaboration with US Experts
|
|
imperatore
|
245 |
71K |
15 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
245
|
71K
|
15
|
|